Beyond the Herceptin hype…

Anna Wagstaff

Herceptin may turn out to be the biggest advance in treating breast cancer since tamoxifen. But if we are to prevent soaring drugs bills eating up our health budgets or barring Europe’s poorer patients from the latest therapies, cancer professionals will have to wrest back the debate from the unfettered hype of the mass media.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.